CAS: 1357072-61-7
c-Met inhibitor 1
CAS:1357072-61-7
c-Met inhibitor 1 is a c-Met receptor signaling pathway inhibitor, used for the treatment of …
Fórmula:
C17H14N8S
Pureza:
98.77%
Forma y color:
Solid
Peso molecular:
362.41
Ref: TM-T10655
1mg | 83,00 € | ||
5mg | 170,00 € | ||
10mg | 233,00 € | ||
25mg | 388,00 € | ||
50mg | 577,00 € | ||
100mg | 820,00 € | ||
1mL*10mM (DMSO) | 187,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
Ref: IN-DA009CAK
25mg | 164,00 € | ||
50mg | 187,00 € | ||
100mg | 295,00 € | ||
250mg | 472,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
6-(1-METHYL-1H-PYRAZOL-4-YL)-3-((2-METHYL-2H-INDAZOL-5-YL)THIO)-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE
CAS:1357072-61-7
Pureza:
95.0%
Peso molecular:
362.4200134277344
Ref: 10-F390260
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar | ||
250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
6-(1-Methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-B]pyridazine
CAS:1357072-61-7
6-(1-Methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-B]pyridazine is a cMET inhibitor that blocks the activation of cMET. It has been shown …
Fórmula:
C17H14N8S
Pureza:
Min. 95%
Peso molecular:
362.42 g/mol
Ref: 3D-HEC07261
1mg | Descatalogado | Solicitar información | |
5mg | Descatalogado | Solicitar información | |
10mg | Descatalogado | Solicitar información | |
25mg | Descatalogado | Solicitar información | |
50mg | Descatalogado | Solicitar información |